-2%
- Metformin, the active ingredient in Radimet XR, belongs to the biguanide class of oral hypoglycemic agents. It works by:
- Reducing hepatic glucose production
- Decreasing intestinal glucose absorption
- Enhancing insulin sensitivity by increasing glucose uptake and utilization in peripheral tissues
- Unlike sulfonylureas, metformin does not induce hypoglycemia.
Radimet XR is prescribed for managing Type 2 Diabetes Mellitus, particularly in overweight individuals when diet and exercise alone fail to adequately control blood sugar levels.
Adults: Can be used as a standalone treatment or in combination with other oral antidiabetic drugs or insulin.
Children (10 years and older) and adolescents: Can be used alone or in combination with insulin.
Clinical studies have shown that metformin reduces the risk of diabetes-related complications in overweight adults when used as first-line therapy following the failure of dietary control.